HUP0202267A2 - Pseudomycin amide and ester analogs, method for their preparation and pharmaceutical compositions comprising thereof - Google Patents

Pseudomycin amide and ester analogs, method for their preparation and pharmaceutical compositions comprising thereof

Info

Publication number
HUP0202267A2
HUP0202267A2 HU0202267A HUP0202267A HUP0202267A2 HU P0202267 A2 HUP0202267 A2 HU P0202267A2 HU 0202267 A HU0202267 A HU 0202267A HU P0202267 A HUP0202267 A HU P0202267A HU P0202267 A2 HUP0202267 A2 HU P0202267A2
Authority
HU
Hungary
Prior art keywords
pseudomycin
amide
preparation
pharmaceutical compositions
ester analogs
Prior art date
Application number
HU0202267A
Other languages
Hungarian (hu)
Inventor
Shu Hui Chen
Christopher Stanley Galka
Sarah Lynne Hellman
John L Krstenansky
Michael John Rodriguez
Xicheng David Sun
Alexander Ya Usyatinsky
Venkatraghavan Vasudevan
Mark James Zweifel
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of HUP0202267A2 publication Critical patent/HUP0202267A2/en
Publication of HUP0202267A3 publication Critical patent/HUP0202267A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU0202267A 1999-07-15 2000-06-08 Pseudomycin amide and ester analogs, method for their preparation and pharmaceutical compositions comprising thereof HUP0202267A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14398199P 1999-07-15 1999-07-15

Publications (2)

Publication Number Publication Date
HUP0202267A2 true HUP0202267A2 (en) 2002-10-28
HUP0202267A3 HUP0202267A3 (en) 2002-11-28

Family

ID=22506548

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0202267A HUP0202267A3 (en) 1999-07-15 2000-06-08 Pseudomycin amide and ester analogs, method for their preparation and pharmaceutical compositions comprising thereof

Country Status (11)

Country Link
EP (1) EP1198473A1 (en)
JP (1) JP2003505399A (en)
CN (1) CN1362966A (en)
AU (1) AU5725000A (en)
BR (1) BR0013163A (en)
CA (1) CA2379321A1 (en)
EA (1) EA200200165A1 (en)
HU (1) HUP0202267A3 (en)
MX (1) MXPA02000312A (en)
NO (1) NO20020186L (en)
WO (1) WO2001005817A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2396513A1 (en) * 1999-12-13 2001-06-14 Yanzhi Zhang Pseudomycin phosphate prodrugs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5576298A (en) * 1992-11-30 1996-11-19 Research And Development Institute, Inc. At Montana State University Peptides from pseudomonas syringae possessing broad-spectrum antibiotic activity

Also Published As

Publication number Publication date
MXPA02000312A (en) 2002-06-21
AU5725000A (en) 2001-02-05
NO20020186L (en) 2002-03-04
HUP0202267A3 (en) 2002-11-28
EP1198473A1 (en) 2002-04-24
NO20020186D0 (en) 2002-01-14
WO2001005817A1 (en) 2001-01-25
CN1362966A (en) 2002-08-07
JP2003505399A (en) 2003-02-12
BR0013163A (en) 2002-04-02
EA200200165A1 (en) 2002-06-27
CA2379321A1 (en) 2001-01-25

Similar Documents

Publication Publication Date Title
HUP0004123A2 (en) Carboxylic acid amide derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0105108A3 (en) Amide compounds, process for their preparation and pharmaceutical compositions containing them
HUP0201278A3 (en) Pyrazolecarboamide derivative, its preparation, pharmaceutical compositions containing it and its intermediates
IL138533A0 (en) Pharmaceutical compositions for prolonged peptide release and preparation method
HUP0202513A2 (en) Betha-carboline pharmaceutical compositions
HUP0103376A3 (en) New 3-aryl-2-hydroxypropionic acid derivative, pharmaceutical compositions containing it, process for their preparation and their use
HK1065952A1 (en) Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it
HUP0301325A3 (en) Stabilized pharmaceutically effective composition and pharmaceutical composition comprising the same and process for preparation the composition
GB0028088D0 (en) Pharmaceutical compositions
GB0001662D0 (en) Pharmaceutical compositions
HUP0104762A3 (en) Pharmaceutical moxifloxacin compositions and process for their preparation
HUP0202762A3 (en) Solid lipid compositions, process for their preparation and use thereof
GB9923436D0 (en) Pharmaceutical compositions
HUP0201402A3 (en) Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them
HUP0302130A3 (en) Combination pharmaceutical compositions and process for their preparation
HUP0001632A3 (en) Pharmaceutical compositions comprising selective phosphodiestherase inhibitors
HUP0105204A3 (en) Substituted phenethylamine derivatives and pharmaceutical compositions containing them
GB9904163D0 (en) Pharmaceutical compositions
HUP0302912A3 (en) Betha-thio-amino acids, process for their preparation and pharmaceutical compositions containing them
HUP0202988A3 (en) Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one derivatives and their use as lipase inhibitors, process for their preparation and pharmaceutical compositions containing them
HUP0101234A3 (en) Betha-carboline derivatives, process for their preparation and pharmaceutical compositions thereof
HUP0202732A3 (en) Amide compounds and pharmaceutical compositions containing them
HUP0202267A2 (en) Pseudomycin amide and ester analogs, method for their preparation and pharmaceutical compositions comprising thereof
GB9904911D0 (en) Pharmaceutical compositions
HUP0202305A2 (en) Novel vitamin d analogues, process for their preparation and pharmaceutical compositions containing them